News

Masonic Cancer Center Logo

University of Minnesota Researchers Awarded $2.06M Grant from The NCI

Leaders in the Program in Health Disparities Research (PHDR) and the Masonic Cancer Center, University of Minnesota recently received a $2,063,688 award from the National Cancer Institute/National Institutes of Health for their R25 project…
Shernan Holtan, MD

FDA Grants Orphan Drug Designation for New Treatment for Life-Threatening Acute GVHD Developed at the University of Minnesota

The FDA has granted Orphan Drug Designation to urinary-derived human chorionic gonadotropin and epidermal growth factor (uhCG/EGF, most commonly available as Pregnyl®) for the treatment of acute graft-versus-host-disease (GVHD). This…
David Ingbar, MD, and John E. Wagner, MD

University of Minnesota opens clinical trial for new treatment of COVID-19

A patient with COVID-19 and lung failure at the University of Minnesota is the first to be treated in the U.S. on a new FDA-approved clinical trial determining the safety and effectiveness of mesenchymal stem cells (MSCs). This new…
Joshua Rhein, MD, and Jeffrey Miller, MD

University of Minnesota expands clinical investigation of engineered iPSC-derived NK cells, opening U.S. clinical trial for the treatment of COVID-19

The first patient has received treatment in a new clinical trial that has opened at the University of Minnesota to test whether a novel cell therapy currently under clinical investigation as a treatment for acute myeloid leukemia (AML) and…
Minnesota Cancer Center

2020 Health Disparities & Cancer Research Summer Internship

This summer the University of Minnesota Medical School Program in Health Disparities Research (PHDR) and the Masonic Cancer Center are hosting the 11th annual Health Disparities & Cancer Research Summer Internship program. This…
Kolawole S. Okuyemi, MD, MPH, and David Horne, PhD

Kolawole S. Okuyemi and David Horne Added to Masonic Cancer Center’s External Advisory Board

Kolawole S. Okuyemi, MD, MPH, and David Horne, PhD, will join the External Advisory Board of the Masonic Cancer Center, University of Minnesota.
Lindsey Sloan

Lindsey Sloan, MD, PhD, set to join Medical School and Masonic Cancer Center

The University of Minnesota Medical School’s Department of Radiation Oncology announces the appointment of Lindsey Sloan, MD, PhD, as an assistant professor starting July 31, 2020. Sloan, a radiobiologist, will also join the Masonic Cancer…
Glove and vial

Masonic Cancer Center Members Awarded NCI Research Grants

The following Masonic Cancer Center members are the Principal Investigators on projects that were awarded National Cancer Institute (NCI) Research Grants in the latest grant cycle. R01:
Helen Parsons, PhD, MPH

University of Minnesota Researcher Awarded 2020 Order of the Eastern Star Scholar Award

Helen Parsons, PhD, MPH, was named the 2020 Order of the Eastern Star Scholar, an honor recognizing her commitment to the Masonic Cancer Center and to the Order’s extraordinary commitment to supporting the development of novel therapies…
Masonic Cancer Center U of M

Faculty promotions for Masonic Cancer Center Members

A number of Masonic Cancer Center members recently received promotions in their home base colleges.College of Biological Sciences Biochemistry, Molecular Biology and Biophysics    Yue Chen, PhD, promoted to Associate…